Aterian, Inc. (NASDAQ:ATER) Short Interest Up 76.9% in December

Aterian, Inc. (NASDAQ:ATERGet Free Report) saw a significant increase in short interest in the month of December. As of December 31st, there was short interest totaling 289,004 shares, an increase of 76.9% from the December 15th total of 163,339 shares. Approximately 3.6% of the shares of the company are short sold. Based on an average daily trading volume, of 79,792 shares, the days-to-cover ratio is currently 3.6 days. Based on an average daily trading volume, of 79,792 shares, the days-to-cover ratio is currently 3.6 days. Approximately 3.6% of the shares of the company are short sold.

Aterian Stock Up 2.1%

NASDAQ ATER opened at $0.77 on Friday. The company has a market cap of $7.75 million, a PE ratio of -0.48 and a beta of 0.03. Aterian has a 52 week low of $0.64 and a 52 week high of $3.50. The firm’s 50-day simple moving average is $0.77 and its two-hundred day simple moving average is $1.01.

Aterian (NASDAQ:ATERGet Free Report) last posted its quarterly earnings results on Thursday, November 13th. The company reported ($0.28) earnings per share (EPS) for the quarter, beating the consensus estimate of ($0.63) by $0.35. The company had revenue of $19.02 million for the quarter, compared to analyst estimates of $19.88 million. Aterian had a negative net margin of 15.73% and a negative return on equity of 47.45%.

Hedge Funds Weigh In On Aterian

Several hedge funds have recently made changes to their positions in the stock. Susquehanna International Group LLP lifted its holdings in Aterian by 310.2% during the 3rd quarter. Susquehanna International Group LLP now owns 40,512 shares of the company’s stock worth $43,000 after purchasing an additional 30,637 shares in the last quarter. Ground Swell Capital LLC bought a new stake in shares of Aterian during the second quarter valued at about $58,000. Citadel Advisors LLC lifted its holdings in shares of Aterian by 222.0% in the third quarter. Citadel Advisors LLC now owns 33,165 shares of the company’s stock worth $35,000 after buying an additional 22,865 shares in the last quarter. XTX Topco Ltd bought a new position in shares of Aterian in the second quarter valued at approximately $55,000. Finally, Goldman Sachs Group Inc. grew its stake in Aterian by 73.0% during the first quarter. Goldman Sachs Group Inc. now owns 21,392 shares of the company’s stock valued at $45,000 after acquiring an additional 9,026 shares in the last quarter. 7.02% of the stock is currently owned by hedge funds and other institutional investors.

Wall Street Analyst Weigh In

Separately, Weiss Ratings reiterated a “sell (e+)” rating on shares of Aterian in a research note on Wednesday, October 8th. One equities research analyst has rated the stock with a Hold rating and one has assigned a Sell rating to the company. Based on data from MarketBeat, the company has a consensus rating of “Reduce” and a consensus target price of $4.00.

View Our Latest Stock Report on Aterian

Aterian Company Profile

(Get Free Report)

Aterian Inc is a technology-driven consumer products company that leverages artificial intelligence and machine learning to develop, source and market branded household, health and personal care products. Through its proprietary data analytics platform, Aterian identifies emerging trends, forecasts demand and optimizes product selection, pricing and distribution. The company maintains a vertically integrated supply chain, overseeing manufacturing partnerships and logistics to support rapid product development and market entry.

Aterian’s portfolio spans a range of categories including home and kitchen, health and wellness, baby care, beauty tools and electronics accessories.

Further Reading

Receive News & Ratings for Aterian Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Aterian and related companies with MarketBeat.com's FREE daily email newsletter.